Medindia
Advertisement

Treatment Outcomes for TB Patients Predicted by Imaging Techniques

by Vani Pradeep on December 6, 2014 at 3:48 PM

Treatment Outcomes for TB Patients Predicted by Imaging Techniques
Positron emission tomography (PET) and computed tomography (CT) are two medical imaging techniques can be reliably used together as a biomarker to help predict the effectiveness of antibiotic drug regimens. This is being tested to treat tuberculosis (TB) patients, according to researchers at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. With multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) on the rise worldwide, new biomarkers are needed to determine whether a particular TB drug regimen is effective.
Advertisement

Traditionally used to detect cancer, PET imaging shows how organs and tissues are functioning. When used with X-rays generated from CT scans, PET scans provide a more complete picture of the area of the body being examined. In two separate studies, NIAID scientists and collaborators demonstrated the utility of PET/CT imaging in monitoring antibiotic treatment effects in both TB-infected monkeys and humans. In the first study, researchers monitored macaques treated with two antibiotics by observing changes on PET/CT scans as well as determining the amount of bacteria remaining after treatment in the animals' lungs, the standard method for assessing TB therapy effectiveness. The researchers applied the same approaches to TB-infected people taking one of the antibiotics and found that changes in human PET/CT scans over the course of treatment were comparable to those seen in monkeys.

In the second study, which solely focused on human patients with TB, investigators observed that early changes in PET/CT scans at two months into the course of treatment could more accurately predict patient outcomes at 30 months than traditional sputum cultures. Sputum analyses can be unreliable and are limited in their ability to accurately predict treatment response and disease relapse. Based on the findings, PET/CT technology could be used in clinical trials of investigational drugs or diagnostics to predict the efficacy of a treatment regimen early on, potentially shortening the duration of a trial and saving resources, according to the researchers.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
'Hybrid Immunity' may Help Elude COVID-19 Pandemic
Stroop Effect
Plant-Based Diet may Reduce the Risk of COVID-19
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Tuberculosis AIDS/HIV Silicosis Screening Tests for Tuberculosis 

Recommended Reading
Screening Tests for Tuberculosis
Tuberculin skin test and Interferon - Release Assays are tests used to screen for tuberculosis....
Diet in Tuberculosis
Patients with tuberculosis should eat a healthy diet so that they build up their immunity to fight ....
Genome Sequencing & Social-Network Analysis Looks at TB Outbreak in a Community
Bacterial whole-genome sequencing and social-network analysis greatly improved epidemiological ......
CMR Versus SPECT: Which is Better?
Cardiac MRI is more sensitive than SPECT in diagnosing cardiac problems, according to a recent ......
AIDS/HIV
"AIDS is an epidemic disease, a potentially preventable, deadly infection for which there is no cure...
Silicosis
Silicosis is a lung disease caused by inhalation of crystalline free silica dust. It is characterise...
Tuberculosis
Tuberculosis, caused by Mycobacterium tuberculosis, primarily affects the lung. It may spread to oth...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use